Regulatory Hurdles for Novel Diagnostic Technologies
Haydar Celik, PhDPublished on: 22/06/2024
Discover the regulatory challenges facing novel diagnostic technologies, including liquid biopsy, AI-driven diagnostics, digital pathology, multiplex biomarkers, and evolving FDA regulatory frameworks.
Novel diagnostic technologiesLiquid biopsyPrecision medicineBiomarkersMolecular diagnosticsDigital pathologyWhole Slide ImagingAI diagnosticsMachine learningCompanion diagnosticsFDA regulatory affairsDiagnostic developmentBiotechnologyClinical validationLaboratory innovationIn vitro diagnostics (IVD)Multiplex immunofluorescenceCyTOFMedical devicesRegulatory strategy